Company WOOJUNG BIO, Inc.

Equities

A215380

KR7215380007

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
1,561 ^KRW	-4.00%		-5.96%	-25.31%

2023	WOOJUNG BIO, Inc. announced that it has received KRW 5 billion in funding from Korea Investment Partners Co. Ltd.	CI
2023	WOOJUNG BIO, Inc. announced that it expects to receive KRW 5 billion in funding from Korea Investment Partners Co. Ltd.	CI

Woojung Bio Inc is a Korea-based company principally engaged in the biological business. The Company operates its business through two segments. The Infection Control Business segment is engaged in the manufacture and sale of reagents, breeding equipment, hydrogen peroxide sterilizers and other products. The Biological Business segment is engaged in the provision of test agency, research service and passage management services.

KRW in Million	2022	Weight	2023	Weight	Delta
Infection Control 80.0 %	35,531	75.7 %	30,903	80.0 %	-13.03%
Bio 19.6 %	11,387	24.3 %	7,553	19.6 %	-33.67%
Lab Cloud 0.4 %	-	-	160	0.4 %	-

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 98.0 %	45,721	97.4 %	37,846	98.0 %	-17.22%
Asia 1.8 %	1,143	2.4 %	712	1.8 %	-37.74%
Europe 0.1 %	54	0.1 %	58	0.1 %	+6.67%

Managers	Title	Age	Since
Byung-Nyeon Cheon CEO	Chief Executive Officer	66	94-08-31
Jin-Hyeon Jeong IND	Independent Dir/Board Member	65	-
Chan-Hyung Hong BRD	Director/Board Member	49	04-04-30
Jin-Woo Kim BRD	Director/Board Member	50	97-01-31
Min-Geun Jo PRN	Corporate Officer/Principal	46	-
Gun Oh AUD	Comptroller/Controller/Auditor	66	-

Members of the board	Title	Age	Since
Jong-Wook Lee CHM	Chairman	75	-
Byung-Nyeon Cheon CEO	Chief Executive Officer	66	94-08-31
Jin-Woo Kim BRD	Director/Board Member	50	97-01-31
Chan-Hyung Hong BRD	Director/Board Member	49	04-04-30
Jin-Hyeon Jeong IND	Independent Dir/Board Member	65	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	2,047,777	0	0	54.30 %
Stock B	1	13,639,326	7,406,703 ( 54.30 %)	159,040 ( 1.166 %)

Name	Equities	%	Valuation
SUSUNG Asset Management Co., Ltd. 41.24 %	910,122	41.24 %	1 M ₩

WOOJUNG BIO, Inc.

593 Dongtangiheung-ro

18469, Hwaseong-si

http://www.woojungbsc.co.kr

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
WOOJUNG BIO, INC.	-25.31%	16.46M
MODERNA, INC.	+33.63%	50.85B
IQVIA HOLDINGS INC.	-0.09%	42.82B
LONZA GROUP AG	+49.62%	42.03B
CELLTRION, INC.	-4.96%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	19.13B
BIO-TECHNE CORPORATION	+8.61%	13.05B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.08B

Other Biotechnology & Medical Research